174 related articles for article (PubMed ID: 17070067)
1. Inflammation but not oxidative stress is associated with beta-chemokine levels and prevalence of cardiovascular disease in uraemic patients.
Pawlak K; Pawlak D; Myśliwiec M
Cytokine; 2006 Sep; 35(5-6):258-62. PubMed ID: 17070067
[TBL] [Abstract][Full Text] [Related]
2. Circulating beta-chemokines and matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system in hemodialyzed patients--role of oxidative stress.
Pawlak K; Pawlak D; Mysliwiec M
Cytokine; 2005 Jul; 31(1):18-24. PubMed ID: 15896974
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress influences CC-chemokine levels in hemodialyzed patients.
Pawlak K; Pawlak D; Mysliwiec M
Nephron Physiol; 2004; 96(4):p105-12. PubMed ID: 15122056
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis intensified oxidative stress, MIP-1beta and RANTES plasma levels in uraemic patients.
Pawlak K; Pawlak D; Mysliwiec M
Cytokine; 2004 Dec; 28(6):197-204. PubMed ID: 15566948
[TBL] [Abstract][Full Text] [Related]
5. Tissue factor and urokinase-type plasminogen activator system are related to the presence of cardiovascular disease in hemodialysis patients.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Res; 2007; 120(6):871-6. PubMed ID: 17331567
[TBL] [Abstract][Full Text] [Related]
6. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
Afzali B; Bakri RS; Bharma-Ariza P; Lumb PJ; Dalton N; Turner NC; Wierzbicki AS; Crook MA; Goldsmith DJ
J Nephrol; 2003; 16(4):540-5. PubMed ID: 14696756
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress, phosphate and creatinine levels are independently associated with vascular endothelial growth factor levels in patients with chronic renal failure.
Pawlak K; Mysliwiec M; Pawlak D
Cytokine; 2008 Jul; 43(1):98-101. PubMed ID: 18455421
[TBL] [Abstract][Full Text] [Related]
8. The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease.
Pawlak K; Domaniewski T; Mysliwiec M; Pawlak D
Atherosclerosis; 2009 May; 204(1):309-14. PubMed ID: 18823890
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers.
Rothenbacher D; Müller-Scholze S; Herder C; Koenig W; Kolb H
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):194-9. PubMed ID: 16239601
[TBL] [Abstract][Full Text] [Related]
10. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.
Panichi V; Taccola D; Rizza GM; Consani C; Migliori M; Filippi C; Paoletti S; Sidoti A; Borracelli D; Panicucci E; Giovannini L
J Nephrol; 2004; 17(5):715-20. PubMed ID: 15593040
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of lipophilic antioxidant vitamins in acute ischemic stroke patients: correlation to inflammation markers and neurological deficits.
Chang CY; Chen JY; Ke D; Hu ML
Nutrition; 2005 Oct; 21(10):987-93. PubMed ID: 16157235
[TBL] [Abstract][Full Text] [Related]
12. Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease.
Youssef MY; Mojiminiyi OA; Abdella NA
Transl Res; 2007 Sep; 150(3):158-63. PubMed ID: 17761368
[TBL] [Abstract][Full Text] [Related]
13. Relationship between plasma resistin concentrations, inflammatory chemokines, and components of the metabolic syndrome in adults.
Aquilante CL; Kosmiski LA; Knutsen SD; Zineh I
Metabolism; 2008 Apr; 57(4):494-501. PubMed ID: 18328350
[TBL] [Abstract][Full Text] [Related]
14. The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure.
Madsen T; Schmidt EB; Christensen JH
J Ren Nutr; 2007 Jul; 17(4):258-63. PubMed ID: 17586424
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between cardiovascular complication and inflammation, oxidative stress of patient with maintenance hemodialysis].
Zuo C; Qiu HY; Li Z; Xie XS; Fan JM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 39(1):119-21, 129. PubMed ID: 18390217
[TBL] [Abstract][Full Text] [Related]
16. High serum hyaluronan indicates poor survival in renal replacement therapy.
Stenvinkel P; Heimbürger O; Wang T; Lindholm B; Bergström J; Elinder CG
Am J Kidney Dis; 1999 Dec; 34(6):1083-8. PubMed ID: 10585318
[TBL] [Abstract][Full Text] [Related]
17. Influence of oral vitamin E therapy on micro-inflammation and cardiovascular disease markers in chronic hemodialysis patients.
Hodkova M; Dusilova-Sulkova S; Kalousova M; Soukupova J; Zima T; Mikova D; Malbohan IM; Bartunkova J
Ren Fail; 2006; 28(5):395-9. PubMed ID: 16825088
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory status in patients with chronic renal failure: the role of PTX3 and pro-inflammatory cytokines.
Malaponte G; Libra M; Bevelacqua Y; Merito P; Fatuzzo P; Rapisarda F; Cristina M; Naselli G; Stivala F; Mazzarino MC; Castellino P
Int J Mol Med; 2007 Oct; 20(4):471-81. PubMed ID: 17786277
[TBL] [Abstract][Full Text] [Related]
19. IL-18 is involved in vascular injury in end-stage renal disease patients.
Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular disease in renal allograft recipients is associated with elevated sialic acid or markers of inflammation.
Bakri RS; Afzali B; Covic A; Sriskantharan R; Bharma-Ariza P; Park WH; Sriharan M; Dalton N; Wierzbicki AS; Crook MA; Goldsmith DJ
Clin Transplant; 2004 Apr; 18(2):201-4. PubMed ID: 15016136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
